Literature DB >> 19578990

Using patient DNA to optimize therapy in heart failure patients: a move toward perfection.

Howard L McLeod1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 19578990     DOI： 10.1007/s10741-009-9150-1

Source DB:  PubMed          Journal:  Heart Fail Rev        ISSN： 1382-4147            Impact factor:   4.214


× No keyword cloud information.
  16 in total

Review 1.  Pharmacogenomics: translating functional genomics into rational therapeutics.

Authors:  W E Evans; M V Relling
Journal:  Science       Date:  1999-10-15       Impact factor: 47.728

Review 2.  Better therapeutics through microarrays.

Authors:  David L Gerhold; Roderick V Jensen; Steven R Gullans
Journal:  Nat Genet       Date:  2002-12       Impact factor: 38.330

Review 3.  Inheritance and drug response.

Authors:  Richard Weinshilboum
Journal:  N Engl J Med       Date:  2003-02-06       Impact factor: 91.245

4.  Polymorphisms of cardiac presynaptic alpha2C adrenergic receptors: Diverse intragenic variability with haplotype-specific functional effects.

Authors:  Kersten M Small; Jeanne Mialet-Perez; Carrie A Seman; Cheryl T Theiss; Kari M Brown; Stephen B Liggett
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-19       Impact factor: 11.205

Review 5.  Pharmacogenetic perspectives gained from twin and family studies.

Authors:  E S Vesell
Journal:  Pharmacol Ther       Date:  1989       Impact factor: 12.310

Review 6.  Genome-wide association studies for common diseases and complex traits.

Authors:  Joel N Hirschhorn; Mark J Daly
Journal:  Nat Rev Genet       Date:  2005-02       Impact factor: 53.242

Review 7.  Genome-wide association studies: theoretical and practical concerns.

Authors:  William Y S Wang; Bryan J Barratt; David G Clayton; John A Todd
Journal:  Nat Rev Genet       Date:  2005-02       Impact factor: 53.242

Review 8.  Genomic and proteomic profiling for biomarkers and signature profiles of toxicity.

Authors:  B Alex Merrick; Maribel E Bruno
Journal:  Curr Opin Mol Ther       Date:  2004-12

Review 9.  Pharmacogenomics: the inherited basis for interindividual differences in drug response.

Authors:  W E Evans; J A Johnson
Journal:  Annu Rev Genomics Hum Genet       Date:  2001       Impact factor: 8.929

10.  Direct molecular haplotyping by melting curve analysis of hybridization probes: beta 2-adrenergic receptor haplotypes as an example.

Authors:  Genevieve Pont-Kingdon; Elaine Lyon
Journal:  Nucleic Acids Res       Date:  2005-06-03       Impact factor: 16.971
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.